Icosapent ethyl
Vascepa, Vazkepa (icosapent ethyl) is a small molecule pharmaceutical. Icosapent ethyl was first approved as Vascepa on 2012-07-26. It has been approved in Europe to treat dyslipidemias. Vascepa's patents are valid until 2033-06-28 (FDA).
| Trade Name | Vazkepa |
|---|---|
| Common Name | Icosapent ethyl |
| Indication | dyslipidemias |
| Drug Class | Antilipemic Agents |
